Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Lars Ottestad*, Line Fronth, Sajitha Rajendiran, Liv Hege Aksnes, Hans Petter Eikesdal, Egil Støre Blix, Marianne Ewertz

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind58
Udgave nummer3
Sider (fra-til)385-387
ISSN0284-186X
DOI
StatusUdgivet - 4. mar. 2019

Citer dette

Ottestad, Lars ; Fronth, Line ; Rajendiran, Sajitha ; Hege Aksnes, Liv ; Eikesdal, Hans Petter ; Støre Blix, Egil ; Ewertz, Marianne. / Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer. I: Acta Oncologica. 2019 ; Bind 58, Nr. 3. s. 385-387.
@article{4e5cd7ec7e864fd1bc2270b37e61eb4f,
title = "Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer",
keywords = "Aged, Aged, 80 and over, Androstadienes/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/drug therapy, Everolimus/administration & dosage, Female, Follow-Up Studies, Humans, Middle Aged, Postmenopause, Prognosis, Receptor, ErbB-2/metabolism, Receptors, Estrogen/metabolism, Receptors, Progesterone/metabolism, Survival Rate",
author = "Lars Ottestad and Line Fronth and Sajitha Rajendiran and {Hege Aksnes}, Liv and Eikesdal, {Hans Petter} and {St{\o}re Blix}, Egil and Marianne Ewertz",
year = "2019",
month = "3",
day = "4",
doi = "10.1080/0284186X.2019.1566771",
language = "English",
volume = "58",
pages = "385--387",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & Francis",
number = "3",

}

Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer. / Ottestad, Lars; Fronth, Line; Rajendiran, Sajitha; Hege Aksnes, Liv; Eikesdal, Hans Petter; Støre Blix, Egil; Ewertz, Marianne.

I: Acta Oncologica, Bind 58, Nr. 3, 04.03.2019, s. 385-387.

Publikation: Bidrag til tidsskriftLetterForskningpeer review

TY - JOUR

T1 - Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

AU - Ottestad, Lars

AU - Fronth, Line

AU - Rajendiran, Sajitha

AU - Hege Aksnes, Liv

AU - Eikesdal, Hans Petter

AU - Støre Blix, Egil

AU - Ewertz, Marianne

PY - 2019/3/4

Y1 - 2019/3/4

KW - Aged

KW - Aged, 80 and over

KW - Androstadienes/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Breast Neoplasms/drug therapy

KW - Everolimus/administration & dosage

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Middle Aged

KW - Postmenopause

KW - Prognosis

KW - Receptor, ErbB-2/metabolism

KW - Receptors, Estrogen/metabolism

KW - Receptors, Progesterone/metabolism

KW - Survival Rate

U2 - 10.1080/0284186X.2019.1566771

DO - 10.1080/0284186X.2019.1566771

M3 - Letter

VL - 58

SP - 385

EP - 387

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 3

ER -